Showing all 4 results
Facioscapulohumeral Muscular Dystrophy PBMC
Facioscapulohumeral Muscular Dystrophy PBMC samples are isolated from donors with genetically confirmed facioscapulohumeral muscular dystrophy (FSHD). Ideal for investigating immune involvement in muscle degeneration, inflammation-related pathways, and potential therapeutic targets in dystrophic muscle disease.
Facioscapulohumeral Muscular Dystrophy Plasma
Facioscapulohumeral Muscular Dystrophy Plasma samples are collected from donors diagnosed with facioscapulohumeral muscular dystrophy (FSHD). Suitable for analyzing muscle damage biomarkers, proinflammatory cytokines, and circulating proteins linked to disease activity and progression.
Facioscapulohumeral Muscular Dystrophy Serum
Facioscapulohumeral Muscular Dystrophy Serum samples are derived from donors with confirmed facioscapulohumeral muscular dystrophy (FSHD). Useful for measuring creatine kinase levels, immune mediators, and markers of muscle injury and systemic inflammation.
Facioscapulohumeral Muscular Dystrophy Whole Blood
Facioscapulohumeral Muscular Dystrophy Whole Blood samples are obtained from donors with clinically and genetically diagnosed facioscapulohumeral muscular dystrophy (FSHD). Valuable for transcriptomic studies, immune cell profiling, and identifying gene expression patterns associated with DUX4 activation and muscular dystrophy pathology.